Transrectal ultrasound in the diagnosis of prostate cancer: state of the art and perspectives
| Autor: | Johan G. Braeckman, T.M. De Reijke, P. Kil, Ad J.M. Hendrikx, P. L. M. Vijverberg, J.J.M.C.H. de la Rosette, J.P.M. Sedelaar |
|---|---|
| Přispěvatelé: | Other departments |
| Rok vydání: | 2001 |
| Předmět: |
Gynecology
Male medicine.medical_specialty Surgical approach business.industry Urology Ultrasound Rectum Prostatic Neoplasms Ultrasonography Doppler urologic and male genital diseases medicine.disease Toepassingen van biomedische technieken in de urologie Application of BioMedical Engineering in Urology Prostate cancer medicine.anatomical_structure Prostate medicine Humans Prostate disease Radiology Ultrasonography business Forecasting |
| Zdroj: | European urology, 40(3), 275-284. Elsevier European Urology, 40, 275--84 European Urology, 40, 3, pp. 275--84 |
| ISSN: | 0302-2838 |
| Popis: | Item does not contain fulltext OBJECTIVES: Transrectal ultrasound (TRUS) is an important tool in diagnosing prostate cancer. However, specificity and sensitivity of conventional grey-scale TRUS for the detection of prostate cancer are disappointingly low. New ultrasound modalities are designed to overcome the disappointing results and improve the use of ultrasound in the diagnosis of prostate cancer. This work is a review of the recent literature, combined with own experiences. METHODS: The papers were collected using a Medline search, combined with some papers by author selection. The terms used for the Medline search included among other things: transrectal ultrasound, prostate, prostate cancer, prostate biopsies, colour Doppler ultrasound, power Doppler ultrasound, contrast ultrasound. The authors used their own experiences for illustrations of various techniques. RESULTS AND CONCLUSIONS: Although several modalities show a significant improvement in sensitivity and specificity for the detection of prostate cancer, none of the TRUS modalities discussed can replace prostate biopsies as a definitive diagnostic. Several techniques, especially contrast ultrasound, show definitive promise. However, two valid conclusions can be made from the data presented. First: with today's technology, none of the TRUS modalities discussed can replace systemic biopsies in the early detection of prostate cancer. Second: none of the discussed TRUS modalities has found a definitive place in routine clinical practice. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|